The Clinical Trial Finance Analyst II develops complex clinical trial budgets for industry, National Institutes of Health (NIH), and investigator-initiated clinical research. Evaluates research protocols to assess resource needs, procedures, clinical research staff time, investigator time, and costs from ancillary departments. Determines cost allocation, negotiates budgets, details budgets, and responsible for monitoring accounts and invoicing. Ensures compliance with all federal and local agencies including the Food and Drug Administration (FDA) and local Institutional Review Board
In addition, the Clinical Trial Finance Analyst II will be responsible for the following:
Works closely with investigators and ancillary departments to identify research procedures needed, budget estimates and cost details.
Determines whether research procedures in the protocol are standard-of-care or a research-related costs in order to correctly classify expenses.
Develops complex clinical trial budgets for industry and the National Institutes of Health (NIH) as well as investigator-initiated clinical research. Works with the CSMC office of Sponsored Research to develop final budgets for clinical trials and research projects.
Negotiates trial budgets and payment terms with industry sponsors.
Monitors study accounts to evaluate the cost expenses/details are appropriate and within expected limits, reconciles accounts receivable and payments, and recommends the best course of action for any deficits and/or surpluses. Negotiates with sponsors the final payment due for account closeout. May conduct review and/or audits of clinical trial budgets. Serves as a resource for fiscal related questions and engages management as appropriate.
Extracts and defines relevant information, analyzes and interprets data to determine financial performance and/or to project a financial probability and makes recommendations to influence business results. Prepares and delivers data, reports and/or presentations to investigators, management and/or leadership.
Enters financial information from finalized clinical trials budgets and clinical trial agreements into the Clinical Trial Management System. Reviews and finalizes clinical trials calendars to ensure agreement with Medicare coverage analysis and clinical trial budget.
Reviews protocol amendments for impact to sponsored research budget/contract. Process budget/contract amendments as applicable.
May plan and coordinate strategies to improve existing standard operating procedures related to budgeting and clinical trials finance. May identify quality and performance improvement opportunities and collaborate with staff in the development of action plans to improve quality.
Department specific duties:
Responsible for revenue management for external recovery (receivables) and payment to vendors (payables) or sub-sites
Monitoring and facilitating reconciliation of revenue based on protocol activity/visit completion, invoicing, and cash received.
Identify responsible party to invoice for any other agreement/contract supporting clinical research.
Responsible for the financial management of study accounts for clinical research studies sponsored by industry or NIH and for Investigator-Initiated trials.
Monitors study accounts to evaluate that cost details are appropriate and within expected limits and to determine whether proper expenses had been charged.
Monitors study accounts for any deficits and/or surpluses and determine the best course of action.
Identifies amount accrued per executed clinical trial agreement
Issues and submits invoices for both protocol-related items and patient-related expenses per the executed contract
Issues internal invoices for staff time and effort allocation into study accounts
Oversees payment processing for satellite sites and/or affiliates
Responsible for financial closure of study accounts; negotiates with Sponsors the final payment due for account closeout
Maintains research practices using Good Clinical Practice (GCP) guidelines.
Maintains strict patient confidentiality according to HIPAA regulations and applicable law.
Participates in required training and education programs.
Providing healthcare for more than 100 years, Cedars-Sinai has evolved into one of the most dynamic and highly renowned medical centers in the world. Along with caring for patients, Cedars-Sinai is a hub for biomedical research and a training center for future physicians and other healthcare professionals. This attracts exceptional talent to Cedars-Sinai, including world-renowned physician-scientists who seek a place where they can both conduct research and see patients--the ideal formula for discovery and its translation into cures. Our patients benefit from access to doctors at the top of their fields, and our researchers have an ideal community in which to study the impact of healthcare challenges, and reflect that knowledge in their research. The greater Los Angeles area in which Cedars-Sinai resides possesses unparalleled cultural and ethnic diversity which offers outstanding opportunities for translational and clinical research... and a dynamic environment for medical education.Although community based, Cedars-Sinai is a major teaching hospital affiliated with the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Cedars-Sinai has highly competitive graduate medical education programs in more than 50 specialty and subspecialty areas, a graduate program in biomedical sciences and translational medicine, a clinical scholars program directed towards junior physicians with aspirations to become clinical scientists, and post graduate training opportunities.There are more than 250 full-time faculty members at Cedars-Sinai. The voluntary medical staff, comprised of more than 2,200 specialty board-certified or board-qualified physicians, represent all of the specialties and subspecialties and collaborate with full-time medical staff in the teaching responsibilities of the graduate medical education programs.